Ms. Windfelder is an associate in McCarter's Product Liability group. In addition to pharmaceutical and medical device product liability litigation, Ms. Windfelder’s practice includes patent litigation and antitrust disputes. Ms. Windfelder has been involved in defending major pharmaceutical companies in various state and federal product liability, antitrust and patent litigations where she has assisted with witness preparation, interviewing and advising company employees, and liaising with regional and national defense counsel on a variety of issues. Ms. Windfelder is skilled in large scale discovery management. She has successfully negotiated numerous protocols governing the production of electronically stored information (“ESI”), coordinated substantial electronic, hard copy document and database productions, including management of review and production of technically complex structured data sets.
Ms. Windfelder has considerable experience in the electronic discovery arena. She serves on McCarter's E-Discovery Committee and is a member of the SEDONA CONFERENCE® Working Group on Electronic Document Retention and Production. Ms. Windfelder is well-versed in document preservation obligations as well as defensible coordination, management and implementation of international document and database discovery; drafting protocols to effectively oversee such discovery; EU privacy considerations; back-up tape restoration; and management of multiple, simultaneous, complex document reviews.
In her general practice, Ms. Windfelder has experience litigating arbitrations and disputes in both federal and state courts in Delaware, New Jersey and Pennsylvania.
Ms. Windfelder is actively engaged in providing pro bono representation to clients through Delaware Volunteer Legal Services, which contributed to the Delaware State Bar Association awarding McCarter & English the Leadership Award for its commitment to Delaware’s indigent population.
Prior to joining McCarter, Ms. Windfelder worked for in sales and marketing for two global pharmaceutical companies.